Search Medical Condition
Please enter condition
Please choose location from dropdown

Heart Failure Clinical Trials

A listing of Heart Failure medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (857) clinical trials

The purpose of this trial is to develop valid scientific evidence for safety and effectiveness of Baroreflex Activation Therapy® with the BAROSTIM NEO® System in subjects with heart failure, defined as New York Heart Association (NYHA) functional class III and left ventricular ejection fraction (LVEF) = 35% despite being treated ...

Phase N/A

This is an event-driven Phase IIIb, multicentre, randomised, clinical study to demonstrate the efficacy of AdreView™ imaging for appropriately guiding the decision of implantable cardioverter defibrillator (ICD) implantation, in New York Health Association (NYHA) class II and III heart failure patients with 30%=left ventricular ejection fraction (LVEF)=35%%, and in particular, ...

Phase

CRT implant strategy using the longest electrical delay for non-left bundle branch block patients (Enhance CRT). 

Phase N/A

The primary objective of this study is to assess the effect of oral treprostinil compared with placebo on change in exercise capacity as measured by change in 6MWD from Baseline to Week 24 in subjects with PH associated with HFpEF. There are no approved treatments for PH in subjects with ...

Phase

A research study is evaluating an investigational oral medication for Chronic Heart Failure. This research study may be an option if you: Are between 18 and 85 years of age Have been diagnosed with chronic heart failure and have been receiving treatment for at least 30 days Have not had ...

Phase N/A

People with Heart Failure are asked to participate in a research study being conducted by Montefiore Medical Center.

Phase N/A

Multi-center, prospective, single-arm, continued access study of the Optimizer Smart System with CCM therapy. All subjects will be followed until the PMA order has been issued by the FDA. The protocol is designed to collect adverse safety events, quality of life data and data needed for comparison with long term ...

Phase N/A

The objective of this event-driven trial is to demonstrate superiority of empagliflozin 10 mg versus placebo on top of guideline-directed medical therapy in patients with symptomatic, chronic HF and reduced ejection fraction (LVEF ≤ 40%). Patients with chronic HF diagnosed for at least 3 months before Visit 1.

Phase

Male and female subjects aged 18 years or older, with chronic HF (NYHA class II-IV), reduced ejection fraction (< 45%), elevated natriuretic peptides, and previous HFdecompensation (defined as HF hospitalization or use of IV diuretics for HF [without hospitalization]) will be enrolled in this trial.

Phase N/A

A research study is evaluating an investigational oral medication for Chronic Heart Failure. This research study may be an option if you: Are between 18 and 85 years of age Have been diagnosed with chronic heart failure and have been receiving treatment for at least 30 days Have not had ...

Phase N/A